Establishing causality in the assessment of safety of medicines for children.
Data on safety of medicines in children typically arises from various sources, rendering assessment of causality challenging. We outline these sources, together with their strengths and weaknesses. Bradford Hill proposed criteria for assessment of causality of observed associations; we explore their utility in this context. Collaborations between clinicians, epidemiologists and clinical pharmacologists, making intelligent use of both older and newer methodologies, can help make the use of medicines in children safer.